Chemokine receptor 7 via proline-rich tyrosine kinase-2 upregulates the chemotaxis and migration ability of squamous cell carcinoma of the head and neck

Oncology Reports

Volumn 28, Issue 5, 2012, Pages 1659-1664

  Yang, Liangliang ^a   Liu, Fayu ^a   Xu, Zhongfei ^a   Guo, Nan ^a   Zheng, Xiaojiao ^a   Sun, Changfu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Actin cytoskeleton; Chemokine receptor 7; Migration; Proline rich kinase 2; Squamous cell carcinoma of the head and neck

Indexed keywords

ANTINEOPLASTIC AGENT; CHEMOKINE RECEPTOR CCR7; COFILIN; CYTOSKELETON PROTEIN; F ACTIN; FOCAL ADHESION KINASE 2; TYRPHOSTIN A9; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER TISSUE; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; METASTASIS; MIGRATION INHIBITION; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

ACTIN DEPOLYMERIZING FACTORS; ACTINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOTAXIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PHOSPHORYLATION; RECEPTORS, CCR7; SIGNAL TRANSDUCTION; TYK2 KINASE; TYRPHOSTINS; UP-REGULATION;

EID: 84866469804     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1989     Document Type: Article

References (28)

1. Greenlee RT, Hill-Harmon MB, Murray T and Thun M: Cancer Statistics, 2001. CA Cancer J Clin 51: 15-36, 2001. (Pubitemid 32166444)
2. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al : Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001. (Pubitemid 32225831)
3. Ben-Baruch A: Site-specific metastasis formation: chemokines as regulators of tumor cell adhesion, motility and invasion. Cell Adh Migr 3: 328-333, 2009.
4. Wang J, Xi L, Hunt JL, Gooding W, Whiteside TL, Chen Z, Godfrey TE and Ferris RL: Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res 64: 1861-1866, 2004. (Pubitemid 38428712)
5. Zhao ZJ, Liu FY, Li P, Ding X, Zong ZH and Sun CF: CCL19-induced chemokine receptor 7 activates the phosphoinositide-3 kinase-mediated invasive pathway through Cdc42 in metastatic squamous cell carcinoma of the head and neck. Oncol Rep 25: 729-737, 2011.
6. Liu FY, Zhao ZJ, Li P, Ding X, Zong ZH and Sun CF: Mammalian target of rapamycin (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck. Br J Oral Maxillofac Surg 48: 291-296, 2010.
7. Zhen-Jin Z, Peng L, Fa-Yu L, Liyan S and Chang-Fu S: PKCα take part in CCR7/NF-κB autocrine signaling loop in CCR7-positive squamous cell carcinoma of head and neck. Mol Cell Biochem 357: 181-187, 2011.
8. Park SY, Li H and Avraham S: RAFTK/Pyk2 regulates EGF-induced PC12 cell spreading and movement. Cell Signal 19: 289-300, 2007. (Pubitemid 44969978)
9. Picascia A, Stanzione R, Chieffi P, Kisslinger A, Dikic I and Tramontano D: Proline-rich tyrosine kinase 2 regulates proliferation and differentiation of prostate cells. Mol Cell Endocrinol 186: 81-87, 2002. (Pubitemid 34189781)
10. Kuwabara K, Nakaoka T, Sato K, Nishishita T, Sasaki T and Yamashita N: Differential regulation of cell migration and proliferation through proline-rich tyrosine kinase 2 in endothelial cells. Endocrinology 145: 3324-3330, 2004. (Pubitemid 38830004)
11. Roelle S, Grosse R, Buech T, Chubanov V and Gudermann T: Essential role of Pyk2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells. Oncogene 27: 1737-1748, 2008. (Pubitemid 351380271)
12. de Amicis F, Lanzino M, Kisslinger A, Calì G, Chieffi P, Andò S, Mancini FP and Tramontano D: Loss of proline-rich tyrosine kinase 2 function induces spreading and motility of epithelial prostate cells. Cell Physiol 209: 74-80, 2006. (Pubitemid 44318669)
13. Behmoaram E, Bijian K, Jie S, Xu Y, Darnel A, Bismar TA and Alaoui-Jamali MA: Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness. Am J Pathol 173: 1540-1550, 2008
14. Riol-Blanco L, Sánchez-Sánchez N, Torres A, Tejedor A, Narumiya S, Corbí AL, Sánchez-Mateos P and Rodríguez- Fernández JL: The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. J Immunol 174: 4070-4080, 2005. (Pubitemid 40395983)
15. Wang J, Zhang X, Thomas SM, Grandis JR, Wells A, Chen ZG and Ferris RL: Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR. Oncogene 24: 5897-5904, 2005. (Pubitemid 43080081)
16. Liu FY, Zhao ZJ, Li P, Ding X, Guo N, Yang LL, Zong ZH and Sun CF: NF-κB participates in chemokine receptor 7-mediated cell survival in metastatic squamous cell carcinoma of the head and neck. Oncol Rep 25: 383-391, 2011.
17. Li P, Zhao ZJ, Liu FY, Sun LY, Ding X, Zhang WZ, Shang DH and Sun CF: The chemokine receptor 7 regulates cell adhesion and migration via β1 integrin in metastatic squamous cell carcinoma of the head and neck. Oncol Rep 24: 989-995, 2010.
18. Li P, Liu F, Sun L, Zhao Z, Ding X, Shang D, Xu Z and Sun C: Chemokine receptor 7 promotes cell migration and adhesion in metastatic squamous cell carcinoma of the head and neck by activating integrin ανβ3. Int J Mol Med 27: 679-687, 2011.
19. Yuan TC, Lin FF and Veeramani S: ErbB-2 via PYK2 upregulates the adhesive ability of androgen receptor-positive human prostate cancer cells. Oncogene 26: 7552-7559, 2007.
20. Zhang S, Guo D, Jiang L, Zhang Q, Qiu X and Wang E: SOCS3 inhibiting migration of A549 cells correlates with PYK2 signaling in vitro. BMC Cancer 28: 150, 2008.
21. Prasad A, Fernandis AZ, Rao Y and Ganju RK: Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells. J Biol Chem 279: 9115-924, 2004.
22. Fernandis AZ, Prasad A, Band H, Klösel R and Ganju RK: Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 23: 157-167, 2004. (Pubitemid 38142250)
23. Ostergaard HL and Lysechko TL: Focal adhesion kinase-related protein tyrosine kinase Pyk2 in T-cell activation and function. Immunol Res 31: 267-282, 2005.
24. Gismondi A, Jacobelli J, Strippoli R, Mainiero F, Soriani A, Cifaldi L, Piccoli M, Frati L and Santoni A: Proline-rich tyrosine kinase 2 and Rac activation by chemokine and integrin receptors controls NK cell transendothelial migration. J Immunol 170: 3065-3073, 2003. (Pubitemid 36302181)
25. Oser M and Condeelis J: The cofilin activity cycle in lamellipodia and invadopodia. J Cell Biochem 108: 1252-1262, 2009.
26. van Rheenen J, Condeelis J and Glogauer M: A common cofilin activity cycle in invasive tumor cells and inflammatory cells. J Cell Sci 122: 305-311, 2009.
27. Pollard TD and Borisy GG: Cellular motility driven by assembly and disassembly of actin filaments. Cell 112: 453-465, 2003. (Pubitemid 36263079)
28. Sun CK, Ng KT, Lim ZX, Cheng Q, Lo CM, Poon RT, Man K, Wong N and Fan ST: Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition. PLoS One 6: e18878, 2011.